Lazard Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,138
Closed -$2.41M 2629
2024
Q4
$2.41M Sell
47,138
-23,993
-34% -$1.18M ﹤0.01% 819
2024
Q3
$2.93M Buy
71,131
+27,820
+64% +$1.34M ﹤0.01% 774
2024
Q2
$2.08M Buy
43,311
+42,423
+4,777% +$1.88M ﹤0.01% 851
2024
Q1
$42K Sell
888
-64
-7% -$3.42K ﹤0.01% 1754
2023
Q4
$61K Buy
+952
New +$57.3K ﹤0.01% 1842
2022
Q1
Sell
-492
Closed -$44K 2578
2021
Q4
$44K Buy
492
+93
+23% +$7.97K ﹤0.01% 1802
2021
Q3
$32K Sell
399
-27
-6% -$2.27K ﹤0.01% 1870
2021
Q2
$39K Buy
426
+139
+48% +$13.5K ﹤0.01% 1695
2021
Q1
$30K Buy
+287
New +$29.8K ﹤0.01% 1650

Other funds holding NARI

Lazard Asset Management's NARI Position: Q1 2025 in Review

Lazard Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 47,138 shares — an estimated $2.41M sold.

Lazard Asset Management first reported a position in NARI in Q1 2021 and held it in 9 quarters. The position peaked at $2.93M in Q3 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Lazard Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 47,138 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.41M.
  • Lazard Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Lazard Asset Management's Inari Medical, Inc. Common Stock position peaked at $2.93M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.